Zhou J - Search Results

1

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope.

Zafar A, Wang W, Liu G, Xian W, McKeon F, Zhou J, Zhang R. Zafar A, et al. Among authors: zhou j. Cancer Lett. 2021 Jan 1;496:16-29. doi: 10.1016/j.canlet.2020.09.023. Epub 2020 Sep 29. Cancer Lett. 2021. PMID: 33007410 Free PMC article. Review.

2

Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies.

Chen H, Gao Y, Wu J, Chen Y, Chen B, Hu J, Zhou J. Chen H, et al. Among authors: zhou j. Cancer Lett. 2014 Nov 1;354(1):5-11. doi: 10.1016/j.canlet.2014.08.003. Epub 2014 Aug 13. Cancer Lett. 2014. PMID: 25128647 Free PMC article. Review.

3

Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.

Han B, Park D, Li R, Xie M, Owonikoko TK, Zhang G, Sica GL, Ding C, Zhou J, Magis AT, Chen ZG, Shin DM, Ramalingam SS, Khuri FR, Curran WJ, Deng X. Han B, et al. Among authors: zhou j. Cancer Cell. 2015 Jun 8;27(6):852-63. doi: 10.1016/j.ccell.2015.04.010. Epub 2015 May 21. Cancer Cell. 2015. PMID: 26004684 Free PMC article.

4

BH4 domain of Bcl-2 as a novel target for cancer therapy.

Liu Z, Wild C, Ding Y, Ye N, Chen H, Wold EA, Zhou J. Liu Z, et al. Among authors: zhou j. Drug Discov Today. 2016 Jun;21(6):989-96. doi: 10.1016/j.drudis.2015.11.008. Epub 2015 Nov 26. Drug Discov Today. 2016. PMID: 26631752 Free PMC article. Review.

5

A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5.

Wu J, Ding Y, Chen CH, Zhou Z, Ding C, Chen H, Zhou J, Chen C. Wu J, et al. Among authors: zhou z, zhou j. Cancer Lett. 2016 Oct 1;380(2):393-402. doi: 10.1016/j.canlet.2016.06.024. Epub 2016 Jul 4. Cancer Lett. 2016. PMID: 27387452

6

Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets.

Wang P, Liu Z, Chen H, Ye N, Cheng X, Zhou J. Wang P, et al. Among authors: zhou j. Bioorg Med Chem Lett. 2017 Apr 15;27(8):1633-1639. doi: 10.1016/j.bmcl.2017.02.065. Epub 2017 Feb 27. Bioorg Med Chem Lett. 2017. PMID: 28283242 Free PMC article. Review.

7

Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.

Li D, Wang H, Ding Y, Zhang Z, Zheng Z, Dong J, Kim H, Meng X, Zhou Q, Zhou J, Fang L, Shen Q. Li D, et al. Among authors: zhou j, zhou q. Cancer Lett. 2018 Jun 28;424:97-108. doi: 10.1016/j.canlet.2018.03.029. Epub 2018 Mar 23. Cancer Lett. 2018. PMID: 29580806

8

Applications of Bioorthogonal Chemistry in Tumor-Targeted Drug Discovery.

Liu G, Wold EA, Zhou J. Liu G, et al. Among authors: zhou j. Curr Top Med Chem. 2019;19(11):892-897. doi: 10.2174/1568026619666190510091921. Curr Top Med Chem. 2019. PMID: 31074366 Review.

9

Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer.

Liu G, Yin T, Kim H, Ding C, Yu Z, Wang H, Chen H, Yan R, Wold EA, Zou H, Liu X, Ding Y, Shen Q, Zhou J. Liu G, et al. Among authors: zhou j. Eur J Med Chem. 2019 Sep 15;178:589-605. doi: 10.1016/j.ejmech.2019.06.004. Epub 2019 Jun 8. Eur J Med Chem. 2019. PMID: 31220676

10

Molecular targeting therapies for neuroblastoma: Progress and challenges.

Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, Foster J, Zhou J, Zhang R. Zafar A, et al. Among authors: zhou j. Med Res Rev. 2021 Mar;41(2):961-1021. doi: 10.1002/med.21750. Epub 2020 Nov 6. Med Res Rev. 2021. PMID: 33155698 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50,796 results

Search Page